Search research articles
Contact Us
Filters
Showing results (101-110 of 105) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 105 results.
Clinical Pharmacology and Therapeutics
|
October 15, 2024
Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine During Malaria Chemoprevention in Pregnant Women
Norah Mwebaza, Michelle E Roh, Yourong Z Geng, et al.
Gut
|
December 14, 2004
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin
F R Byrne, S Morony, K Warmington, et al.
Chemmedchem
|
December 7, 2020
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Zhonghua Yi Xue Za Zhi
|
May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]
Z F Jiang, F R Xu, J Fan, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 105) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 105 results.
Clinical Pharmacology and Therapeutics
|
October 15, 2024
Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine During Malaria Chemoprevention in Pregnant Women
Norah Mwebaza, Michelle E Roh, Yourong Z Geng, et al.
Gut
|
December 14, 2004
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin
F R Byrne, S Morony, K Warmington, et al.
Chemmedchem
|
December 7, 2020
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Zhonghua Yi Xue Za Zhi
|
May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]
Z F Jiang, F R Xu, J Fan, et al.
Page
of 11